Keyphrases
Aerobic Glycolysis
80%
Alzheimer's Disease
67%
Human Brain
65%
Positron Emission Tomography
63%
Sporadic Alzheimer's Disease
44%
Cerebral Blood Flow
40%
Aging
36%
Metabolic
36%
Blood Flow
35%
Pittsburgh Compound B
33%
Glucose Metabolism
30%
Female Brain
28%
Oxygen Consumption
24%
PET Study
23%
Glycolysis
22%
United States of America
21%
CMRO2
20%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
18%
Oxidative Phosphorylation (OXPHOS)
16%
Brain Metabolism
16%
Magnetic Resonance Imaging
15%
Cerebral Blood Volume
15%
White Matter Hyperintensities
15%
PiB-PET
15%
Arterial Input Function
14%
Skull
14%
Cerebrospinal Fluid Biomarkers
14%
Tinnitus
14%
Low-frequency Repetitive Transcranial Magnetic Stimulation
14%
Temporoparietal Junction
14%
White Matter Hyperintensity Segmentation
14%
Segmentation Method
14%
Amyloid beta
14%
Amyloid Burden
13%
Visual Stimulation
13%
Amyloid Deposition
13%
Repetitive Transcranial Magnetic Stimulation (rTMS)
13%
Cognitively Normal
12%
Nicotinamide Adenine Dinucleotide (NAD+)
11%
Fluorodeoxyglucose
11%
Human Brain Metabolism
11%
Cerebral Glucose Metabolism
11%
Brain Glucose Metabolism
11%
Quantitative Positron Emission Tomography
11%
Oxygen Metabolism
10%
Couture
10%
Callouts
10%
Tinnitus Handicap Inventory
10%
Non-oxidative
10%
Neuroscience
10%
Neuroscience
Positron Emission Tomography
100%
Alzheimer's Disease
90%
Positron Emission Tomography
78%
Amyloid Protein
68%
Metabolic Pathway
60%
Fluorine-18
48%
Oxidative Phosphorylation
36%
Brain Metabolism
30%
Beta Amyloid
24%
In Vivo
23%
Blood Plasma
16%
Functional Magnetic Resonance Imaging
15%
Skull
14%
Temporoparietal Junction
14%
Magnetic Resonance Imaging
14%
Tinnitus
14%
Transcranial Magnetic Stimulation
14%
Electroencephalogram
14%
Meta-Analysis
14%
Neuronal Activity
12%
Functional Connectivity
10%
2-Deoxy-D-Glucose
10%
Visual Cortex
10%
Cerebrovascular Disease
10%
Brain Age
9%
Synaptic Plasticity
9%
Major Depressive Disorder
9%
Intracranial Tumor
8%
Anabolism
7%
Transcranial Doppler
7%
Single-Photon Emission Computed Tomography
7%
Nitroglycerin
7%
Gray Matter
7%
Glucose Transport
7%
Altanserin
7%
Treatment of Depression
7%
Selective Serotonin Reuptake Inhibitor
7%
Positron Emission Tomography-Computed Tomography
7%
5-HT2A Receptor
7%
Receptor Binding
7%
Leflunomide
7%
Mental Disorder
7%
Neuroprotection
6%
Behavior (Neuroscience)
6%
Cognitive Disorders
5%
Neurodegenerative Disorder
5%
Middle Cerebral Artery
5%
Prefrontal Cortex
5%
Medicine and Dentistry
Positron Emission Tomography
60%
Alzheimer's Disease
50%
Aerobic Glycolysis
41%
Brain Blood Flow
29%
Pittsburgh Compound B
28%
Blood Flow
23%
Radioactive Tracer
22%
Polyethylene Terephthalate
22%
4 Iodo 2,5 Dimethoxyamphetamine
21%
Amyloid Protein
20%
Fluorodeoxyglucose
20%
Amyloid Beta
17%
Glucose Metabolism
16%
Neoplasm
14%
Hemodynamic
11%
Fluorodeoxyglucose F 18
10%
Oxidative Phosphorylation
9%
Magnetic Resonance Imaging
8%
Lactic Acid
8%
Intracranial Tumor
8%
Metabolic Rate
8%
Carbon 11
8%
Exercise Test
7%
Cerebrovascular Disease
7%
Temporoparietal Junction
7%
Pyruvic Acid
7%
Repetitive Transcranial Magnetic Stimulation
7%
Glioblastoma
7%
FreeSurfer
7%
Tau
7%
Tinnitus
7%
Leflunomide
7%
Pentetic Acid
7%
Positron Emission Tomography-Computed Tomography
7%
Carotid Artery
7%
Surgery
7%
Oxygen 15
6%
Brain Metabolism
6%
Postoperative Period
5%
Oxygen Consumption
5%
Visual Stimulation
5%